LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 570

Search options

  1. Article ; Online: Human Rad51 Protein Requires Higher Concentrations of Calcium Ions for D-Loop Formation than for Oligonucleotide Strand Exchange.

    Renodon-Corniere, Axelle / Mikawa, Tsutomu / Kuwabara, Naoyuki / Ito, Kentaro / Levitsky, Dmitri / Iwasaki, Hiroshi / Takahashi, Masayuki

    International journal of molecular sciences

    2024  Volume 25, Issue 7

    Abstract: Human Rad51 protein (HsRad51)-promoted DNA strand exchange, a crucial step in homologous recombination, is regulated by proteins and calcium ions. Both the activator protein Swi5/Sfr1 and ... ...

    Abstract Human Rad51 protein (HsRad51)-promoted DNA strand exchange, a crucial step in homologous recombination, is regulated by proteins and calcium ions. Both the activator protein Swi5/Sfr1 and Ca
    MeSH term(s) Humans ; Oligonucleotides ; Rad51 Recombinase ; Calcium ; Ions ; DNA
    Chemical Substances Oligonucleotides ; Rad51 Recombinase (EC 2.7.7.-) ; Calcium (SY7Q814VUP) ; Ions ; DNA (9007-49-2)
    Language English
    Publishing date 2024-03-24
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms25073633
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Enhancement of the thermic effect of food by d-fenfluramine.

    Levitsky, D A / Stallone, D

    Clinical neuropharmacology

    1988  Volume 11 Suppl 1, Page(s) S90–2

    Abstract: Following approximately a week of daily ingestion of fenfluramine, the body weight of female rats is reduced and remains chronically suppressed for as long as treatment is continued. This chronic suppression of body weight by fenfluramine cannot be ... ...

    Abstract Following approximately a week of daily ingestion of fenfluramine, the body weight of female rats is reduced and remains chronically suppressed for as long as treatment is continued. This chronic suppression of body weight by fenfluramine cannot be explained by the anorectic effects of fenfluramine, since food intake returns to normal after about a week. Part of this chronic suppression of body weight lies in the ability of fenfluramine to enhance the thermic effect of food. Fenfluramine ingested by a fasted rat causes no change in metabolic rate. However, following the ingestion of the meal consisting of mixed nutrients or only carbohydrates, the thermic effect of the food is significantly greater than that of the meal without fenfluramine. A similar observation was observed in humans. These observations when combined with the negligible effects of dieting as a means of controlling body weight, argue for the chronic use of fenfluramine as a therapeutic technique to produce sustained weight loss in humans.
    MeSH term(s) Animals ; Body Temperature Regulation/drug effects ; Body Weight/drug effects ; Eating/drug effects ; Energy Metabolism/drug effects ; Female ; Fenfluramine/pharmacology ; Humans ; Male ; Rats
    Chemical Substances Fenfluramine (2DS058H2CF)
    Language English
    Publishing date 1988
    Publishing country United States
    Document type Journal Article
    ZDB-ID 199293-4
    ISSN 1537-162X ; 0362-5664
    ISSN (online) 1537-162X
    ISSN 0362-5664
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Molecular Mechanisms of Pathologies of Skeletal and Cardiac Muscles Caused by Point Mutations in the Tropomyosin Genes.

    Matyushenko, A M / Levitsky, D I

    Biochemistry. Biokhimiia

    2020  Volume 85, Issue Suppl 1, Page(s) S20–S33

    Abstract: The review is devoted to tropomyosin (Tpm) - actin-binding protein, which plays a crucial role in the regulation of contraction of skeletal and cardiac muscles. Special attention is paid to myopathies and cardiomyopathies - severe hereditary diseases of ... ...

    Abstract The review is devoted to tropomyosin (Tpm) - actin-binding protein, which plays a crucial role in the regulation of contraction of skeletal and cardiac muscles. Special attention is paid to myopathies and cardiomyopathies - severe hereditary diseases of skeletal and cardiac muscles associated with point mutations in Tpm genes. The current views on the molecular mechanisms of these diseases and the effects of such mutations on the Tpm structure and functions are considered in detail. Besides, some part of the review is devoted to analysis of the properties of Tpm homodimers and heterodimers with myopathic substitutions of amino acid residues in only one of the two chains of the Tpm dimeric molecule.
    MeSH term(s) Actins/metabolism ; Animals ; Cardiomyopathies/genetics ; Dimerization ; Heterozygote ; Humans ; Models, Molecular ; Muscle Contraction/genetics ; Muscle, Skeletal/pathology ; Muscular Diseases/genetics ; Myocardium/pathology ; Point Mutation ; Protein Binding ; Protein Isoforms ; Tropomyosin/chemistry ; Tropomyosin/genetics ; Tropomyosin/metabolism
    Chemical Substances Actins ; Protein Isoforms ; Tropomyosin
    Language English
    Publishing date 2020-03-19
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1109-5
    ISSN 1608-3040 ; 0006-2979 ; 0320-9717
    ISSN (online) 1608-3040
    ISSN 0006-2979 ; 0320-9717
    DOI 10.1134/S0006297920140023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: The effects of D-fenfluramine on the development of aflatoxin-B1 induced GGT+ hepatic foci in F344 rats.

    Bell, R C / Levitsky, D A / Campbell, T C

    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity

    1993  Volume 17, Issue 4, Page(s) 215–221

    Abstract: ... with aflatoxin-B1 (AFB) and given the drug D-fenfluramine (FEN). Ingestion of this drug leads to a reduction ...

    Abstract The role of total caloric intake and attained body weight in the carcinogenic process in rodents is controversial. In the present study we examined the development of hepatic pre-neoplastic foci in rats treated with aflatoxin-B1 (AFB) and given the drug D-fenfluramine (FEN). Ingestion of this drug leads to a reduction in body weight by increasing the thermogenic response to a meal and by transiently reducing food intake. Young male rats were dosed with AFB or vehicle alone and were then assigned to receive control diet (NO FEN) or control diet + FEN (FEN; 0.15 g/kg diet) for 12-14 weeks. Body weight gain and food intake were reduced among animals given FEN; brown adipose tissue weight (% body weight) was elevated in these groups. Indices of protein status, and concentrations of T3, T4 and insulin did not differ among the groups. All animals given FEN developed GGT+ hepatic foci. The number and volume fraction of foci were significantly larger in FEN relative to NO FEN animals. The mean diameter of foci was slightly enhanced among FEN animals. These results suggest that FEN promotes the development of AFB-induced hepatocellular foci, despite reduced food intake and lower body weight. Since FEN is widely used as a weight loss aid, these findings deserve further study.
    MeSH term(s) Adipose Tissue/drug effects ; Adipose Tissue/metabolism ; Aflatoxin B1 ; Animals ; Blood Chemical Analysis ; Body Weight/drug effects ; Carrier Proteins/drug effects ; Carrier Proteins/metabolism ; Diet ; Eating/drug effects ; Eating/physiology ; Fenfluramine/administration & dosage ; Fenfluramine/pharmacology ; Ion Channels ; Liver Neoplasms/chemically induced ; Liver Neoplasms/metabolism ; Male ; Membrane Proteins/drug effects ; Membrane Proteins/metabolism ; Mitochondrial Proteins ; Organ Size/drug effects ; Rats ; Rats, Inbred F344 ; Uncoupling Protein 1 ; gamma-Glutamyltransferase
    Chemical Substances Carrier Proteins ; Ion Channels ; Membrane Proteins ; Mitochondrial Proteins ; Uncoupling Protein 1 ; Fenfluramine (2DS058H2CF) ; Aflatoxin B1 (9N2N2Y55MH) ; gamma-Glutamyltransferase (EC 2.3.2.2)
    Language English
    Publishing date 1993-04
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1103255-8
    ISSN 0307-0565
    ISSN 0307-0565
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The Continued Impact of Acute Rejection in the Last Decade of Liver Transplantation.

    Harrington, C R / Bittermann, T / Goldberg, D / Levitsky, J

    Gastro hep advances

    2022  Volume 1, Issue 5, Page(s) 686–688

    Language English
    Publishing date 2022-05-10
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2772-5723
    ISSN (online) 2772-5723
    DOI 10.1016/j.gastha.2022.04.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Myopathy-causing mutation R91P in the TPM3 gene drastically impairs structural and functional properties of slow skeletal muscle tropomyosin γβ-heterodimer.

    Gonchar, Anastasiia D / Koubassova, Natalia A / Kopylova, Galina V / Kochurova, Anastasia M / Nefedova, Victoria V / Yampolskaya, Daria S / Shchepkin, Daniil V / Bershitsky, Sergey Y / Tsaturyan, Andrey K / Matyushenko, Alexander M / Levitsky, Dmitrii I

    Archives of biochemistry and biophysics

    2024  Volume 752, Page(s) 109881

    Abstract: Tropomyosin (Tpm) is a regulatory actin-binding protein involved in ... ...

    Abstract Tropomyosin (Tpm) is a regulatory actin-binding protein involved in Ca
    MeSH term(s) Humans ; Tropomyosin/chemistry ; Muscle, Skeletal/metabolism ; Muscular Diseases/genetics ; Mutation ; Muscle Weakness/metabolism ; Actins/genetics ; Actins/metabolism
    Chemical Substances Tropomyosin ; Actins ; TPM3 protein, human
    Language English
    Publishing date 2024-01-06
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 523-x
    ISSN 1096-0384 ; 0003-9861
    ISSN (online) 1096-0384
    ISSN 0003-9861
    DOI 10.1016/j.abb.2023.109881
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Vozmozhnosti laparoskopicheskogo metoda v lechenii rasprostranennogo appendikulyarnogo peritonita.

    Arutyunyan, A S / Blagovestnov, D A / Yartsev, P A / Levitsky, V D / Gulyaev, A A / Kislukhina, E V

    Khirurgiia

    2022  , Issue 7, Page(s) 24–32

    Abstract: Objective: To analyze treatment outcomes in patients with acute appendicitis complicated by widespread peritonitis.: Material and methods: The study included 165 patients acute appendicitis complicated by widespread peritonitis. Inclusion criteria: ... ...

    Title translation Safety and efficacy of laparoscopic approach for widespread appendicular peritonitis.
    Abstract Objective: To analyze treatment outcomes in patients with acute appendicitis complicated by widespread peritonitis.
    Material and methods: The study included 165 patients acute appendicitis complicated by widespread peritonitis. Inclusion criteria: acute appendicitis complicated by widespread peritonitis MIP grade 1-2 in reactive or toxic phase (grading system by Simonyan K.S.), abdominal cavity index ≤16. Exclusion criteria: MIP grade 3, terminal phase, abdominal cavity index ≥17.
    Results: Analysis of postoperative data revealed no correlation between surgical approach and incidence of postoperative intra-abdominal abscesses and infiltrates. In the main group, intra-abdominal abscesses occurred in 4.9% of patients (
    Conclusion: The developed differentiated surgical strategy for patients with appendicular peritonitis is effective and reduces the incidence of wound infection, extra-abdominal complications, and hospital-stay, as well as contributes to early rehabilitation of patients.
    MeSH term(s) Abdominal Abscess/diagnosis ; Abdominal Abscess/etiology ; Abdominal Abscess/surgery ; Appendicitis/complications ; Appendicitis/diagnosis ; Appendicitis/surgery ; Appendix ; Humans ; Laparoscopy/adverse effects ; Peritonitis/diagnosis ; Peritonitis/etiology ; Peritonitis/surgery
    Language Russian
    Publishing date 2022-07-01
    Publishing country Russia (Federation)
    Document type Journal Article
    ZDB-ID 419230-8
    ISSN 2309-5628 ; 0023-1207
    ISSN (online) 2309-5628
    ISSN 0023-1207
    DOI 10.17116/hirurgia202207124
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study.

    Lowe, J / Luber, J / Levitsky, S / Hantak, E / Montgomery, J / Schiestl, N / Schofield, N / Marra, S

    The Journal of cardiovascular surgery

    2007  Volume 48, Issue 3, Page(s) 323–331

    Abstract: ... to conventional methods of hemostasis during cardiac surgery. A next generation fibrin sealant (TISSEEL VH S/D ... detergent [S/D] treatment) to provide added safety and convenience to the currently licensed product ... prospective, randomized, double-blind, multicenter study to compare TISSEEL VH S/D to TISSEEL VH during ...

    Abstract Aim: TISSEEL VH is the only commercially available fibrin sealant indicated as an adjunct to conventional methods of hemostasis during cardiac surgery. A next generation fibrin sealant (TISSEEL VH S/D) has been developed in frozen, ready-to-use form with an added virus inactivation step (solvent/detergent [S/D] treatment) to provide added safety and convenience to the currently licensed product. This study was performed to compare efficacy and safety of the two products.
    Methods: Phase 3, prospective, randomized, double-blind, multicenter study to compare TISSEEL VH S/D to TISSEEL VH during cardiac surgery. The primary efficacy endpoint was the proportion of patients who achieved hemostasis at the primary treatment site within 5 min, and maintained hemostasis until surgical closure.
    Results: The proportion of patients who achieved hemostasis at the primary treatment site within 5 min, and maintained hemostasis until surgical closure was 88.2% for TISSEEL VH S/D and 89.6% for TISSEEL VH in the intent-to-treat population. The difference in proportions, TISSEEL VH S/D minus TISSEEL VH, was 1.4% with a standard error of 3.70%. The lower 97.5% confidence bound of this difference was 8.6%, which is above the predefined noninferiority margin of 15%. Therefore, TISSEEL VH S/D is at least as efficacious as TISSEEL VH. The safety profile of TISSEEL VH S/D was very similar to that of currently licensed TISSEEL VH as assessed by the safety endpoints.
    Conclusion: TISSEEL VH S/D is safe and effective for use as an adjunct to hemostasis in patients undergoing cardiac surgery.
    MeSH term(s) Administration, Topical ; Adult ; Aged ; Aged, 80 and over ; Blood Loss, Surgical/prevention & control ; Cardiac Surgical Procedures ; Cardiopulmonary Bypass ; Double-Blind Method ; Female ; Fibrin Tissue Adhesive/administration & dosage ; Fibrin Tissue Adhesive/adverse effects ; Fibrin Tissue Adhesive/therapeutic use ; Hemostasis, Surgical/methods ; Hemostatics/administration & dosage ; Hemostatics/adverse effects ; Hemostatics/therapeutic use ; Humans ; Male ; Middle Aged ; Postoperative Hemorrhage/prevention & control ; Prospective Studies ; Sternum/surgery ; Time Factors ; Tissue Adhesives/administration & dosage ; Tissue Adhesives/adverse effects ; Tissue Adhesives/therapeutic use ; Treatment Outcome ; United States
    Chemical Substances Fibrin Tissue Adhesive ; Hemostatics ; Tissue Adhesives
    Language English
    Publishing date 2007-06
    Publishing country Italy
    Document type Clinical Trial, Phase III ; Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 80143-4
    ISSN 1827-191X ; 0021-9509
    ISSN (online) 1827-191X
    ISSN 0021-9509
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Essential Light Chains of Myosin and Their Role in Functioning of the Myosin Motor.

    Logvinova, D S / Levitsky, D I

    Biochemistry. Biokhimiia

    2018  Volume 83, Issue 8, Page(s) 944–960

    Abstract: This review summarizes current data on the structure and functions of myosin essential light chains (ELCs) and on their role in functioning of the myosin head as a molecular motor. The data on structural and functional features of the N-terminal ... ...

    Abstract This review summarizes current data on the structure and functions of myosin essential light chains (ELCs) and on their role in functioning of the myosin head as a molecular motor. The data on structural and functional features of the N-terminal extension of myosin ELC from skeletal and cardiac muscles are analyzed; the role of this extension in the ATP-dependent interaction of myosin heads with actin in the molecular mechanism of muscle contraction is discussed. The data on possible interactions of the ELC N-terminal extension with the myosin head motor domain in the myosin ATPase cycle are presented, including the results of the authors' studies that are in favor of such interactions.
    MeSH term(s) Amino Acid Sequence ; Animals ; Humans ; Myosin Light Chains/chemistry ; Myosin Light Chains/metabolism ; Protein Isoforms/chemistry ; Protein Isoforms/metabolism ; Structure-Activity Relationship
    Chemical Substances Myosin Light Chains ; Protein Isoforms
    Language English
    Publishing date 2018-09-25
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1109-5
    ISSN 1608-3040 ; 0006-2979 ; 0320-9717
    ISSN (online) 1608-3040
    ISSN 0006-2979 ; 0320-9717
    DOI 10.1134/S0006297918080060
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: The effects of D-fenfluramine on the development of aflatoxin-B1 induced GGT+ hepatic foci in F344 rats

    Bell, R.C / Levitsky, D.A / Campbell, T.C

    International journal of obesity. Apr 1993. v. 17 (4)

    1993  

    Abstract: ... with aflatoxin-B1 (AFB) and given the drug D-fenfluramine (FEN). Ingestion of this drug leads to a reduction ...

    Abstract The role of total caloric intake and attained body weight in the carcinogenic process in rodents is controversial. In the present study we examined the development of hepatic pre-neoplastic foci in rats treated with aflatoxin-B1 (AFB) and given the drug D-fenfluramine (FEN). Ingestion of this drug leads to a reduction in body weight by increasing the thermogenic response to a meal and by transiently reducing food intake. Young male rats were dosed with AFB or vehicle alone and were then assigned to receive control diet (NO FEN) or control diet + FEN (FEN; 0.15 g/kg diet) for 12-14 weeks. Body weight gain and food intake were reduced among animals given FEN; brown adipose tissue weight (% body weight) was elevated in these groups. Indices of protein status, and concentrations of T3, T4 and insulin did not differ among the groups. All animals given FEN developed GGT+ hepatic foci. The number and volume fraction of foci were significantly larger in FEN relative to NO FEN animals. The mean diameter of foci was slightly enhanced among FEN animals. These results suggest that FEN promotes the development of AFB-induced hepatocellular foci, despite reduced food intake and lower body weight. Since FEN is widely used as a weight loss aid, these findings deserve further study.
    Keywords aflatoxins ; fenfluramine ; energy intake ; body weight ; carcinogenesis ; rats
    Language English
    Dates of publication 1993-04
    Size p. 215-221.
    Document type Article
    ZDB-ID 752409-2
    ISSN 1476-5497 ; 0307-0565
    ISSN (online) 1476-5497
    ISSN 0307-0565
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top